| 25411637
|
Carrageenan nasal spray in virus confirmed common cold: individual patient data analysis of two randomized controlled trials. |
Multidiscip Respir Med |
2014 |
Koenighofer M;Lion T;Bodenteich A;Prieschl-Grassauer E;Grassauer A;Unger H;Mueller CA;Fazekas T |
View
More |
| 34128358
|
Carrageenan nasal spray may double the rate of recovery from coronavirus and influenza virus infections: Re-analysis of randomized trial data. |
Pharmacol Res Perspect |
2021 |
Hemila H;Chalker E |
View
More |
| 34222718
|
The antiviral activity of iota-, kappa-, and lambda-carrageenan against COVID-19: A critical review. |
Clin Epidemiol Glob Health |
2021 |
Frediansyah A |
View
More |
| 34526804
|
The Saliva of Probands Sucking an Iota-Carrageenan Containing Lozenge Inhibits Viral Binding and Replication of the Most Predominant Common Cold Viruses and SARS-CoV-2. |
Int J Gen Med |
2021 |
Morokutti-Kurz M;Unger-Manhart N;Graf P;Rauch P;Kodnar J;Grosse M;Setz C;Savli M;Ehrenreich F;Grassauer A;Prieschl-Grassauer E;Schubert U |
View
More |
| 37830932
|
Preventing upper respiratory tract infections with prophylactic nasal carrageenan: a feasibility study. |
Future Microbiol |
2023 |
Halley C;Honeywill C;Kang J;Pierse N;Robertson O;Rawlinson W;Stelzer-Braid S;Willink R;Crane J |
View
More |
